The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM)

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1184, 2008-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fenofibrate/rosiglitazone interaction: Decreased HDL cholesterol levels: 3 patients

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Paradoxically, serum HDL-cholesterol levels are lowered by concomitant treatment with fenofibrate and rosiglitazone

By  

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Metabolism of Fibric Acid Derivatives

By Spence J.D.  

Clinical Pharmacokinetics, Vol. 34, Iss. 5, 1998-05 ,pp. : 419-420

Adis International

Access to resources Recommend Favorite

Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

By Derosa G   D'Angelo A   Ragonesi PD   Ciccarelli L   Piccinni MN   Pricolo F   Salvadeo S   Montagna L   Gravina A   Ferrari I   Galli S   Paniga S   Cicero AFG  

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 545-555

Field House Publishing

Access to resources Recommend Favorite

Oxymetholone: First report of a decrease in HDL-cholesterol levels: case report

By  

Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite